MedTrace Logo

Dexmedetomidine for Catheter-related Bladder Discomfort

NCT01991223 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 114

Last updated 2014-03-19

No results posted yet for this study

Summary

To evaluate the efficacy of dexmedetomidine for the prevention of catheter-related bladder discomfort

Conditions

Interventions

DRUG

Dex infusion

Dexmedetomidine will be injected (1 mcg/kg for 10 minutes and afterward 0.3 mcg/kg/hr)

DRUG

NS infusion

Normal saline will be infused during surgery

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Hee-Pyoung Park · Seoul National University of Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2014-11-30
Completion
2014-11-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01991223 on ClinicalTrials.gov